Coquenico
Coquenico t1_j6jxzfu wrote
Reply to comment by watabadidea in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
> of course there are other factors involved, but statistical power is always hugely dependent on the raw numbers
always is correct
my very first answer could have specified "always in epidemiology studies", but it was evident from context; unless you've forgotten what this discussion is about (which very much seems to be the case, at this point you just want to convince yourself that you are right to doubt the faithfulness of the original article and whoever defends it)
Coquenico t1_j6jt22j wrote
Reply to comment by watabadidea in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
I've already given answers to these arguments. You're over-interpreting what I've said and have built a straw man that I won't bother taking down
if you want to believe you know, do just that
Coquenico t1_j6jmfqu wrote
Reply to comment by watabadidea in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
> That's the assumptions you've made. That's not the same as that actually being the case, nor is it the same as there being a logical basis to from that conclusion
there's definitely a logical basis :) now of course, you're clearly not honest with me, so I'm only permitted suspicions
Coquenico t1_j6jaziu wrote
Reply to comment by watabadidea in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
> I think that this might highlight your problem here. This idea that it "always" comes down to which scenario has more frequent occurrences is exactly the type of dumbed-down, overgeneralized claim you'd find in a basic statistics book
not at all; I'm not recommending a basic book because it will give you the answer you're looking for, but because it's where you need to start
> Seriously, have you ever been involved in a real-world research study where you were going to have to collect a ton of data and then analyze it?
its my job
> Don't know anything about me.
it seems you have formal training in physics but not in statistics
> Insist on repeatedly stressing how incompetent/untrained/unskilled I am, despite knowing nothing about me.
you keep denying elementary statistical principles, so I assume that you don't have that knowledge
you keep failing to see the problem from a broad statistical perspective. That alone is proof of your incompetence, and why I recommended reading a basic book. You don't have the foundation to transfer your knowledge of physical data analysis to medical data analysis
Coquenico t1_j6f4w9z wrote
Reply to comment by watabadidea in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
there's nothing I can do for you here. You need to read through a basic statistics book. Seems like you have some training in physics so hopefully the mathematical aspects won't be a problem for you
And stop believing people more competent than you on a subject are out to get you. I'm trying to explain in a few lines things you need several years of formal learning to fully understand, of course there are going to be many caveats. That doesn't mean I'm not doing my best to portray things honestly. Now if you don't want to trust me, well, as I said, learn statistics yourself
Coquenico t1_j61ypu7 wrote
Reply to comment by watabadidea in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
> Whenever someone starts off by trying to make it known how much smarter and better educated/trained they are, I know I'm in for some excellent analyses and good faith engagement.
I'm telling you that the answer you're looking is statistical in essence, and that you cannot understand the answer if you do not understand the underlying statistical approach
> So what if the second dice is 10 billion times less fair/more loaded than the first dice?
even if the die always rolled the same number you'd still need at least 5 hours to go anywhere. In those 5 hours you would be able to have detected/excluded very small deviations in the other die (note that you can never exclude extremely small deviations)
So of course there are other factors involved, but statistical power is always hugely dependent on the raw numbers
the current problem isn't like this anyway. Proving that the booster is at most 99% efficient against hospitalization is relatively easy, but it's a result that's useless, as instead the question that's relevant for policy is to get an estimate of its efficiency within a maybe 10% ballpark; is it around 20%, 50%, 80%? So it's the same order of magnitude as for the efficiency on symptoms
> Your stance is that I'm wrong and that the error in my thinking is because of the superior statistical training that you have?
It's not a stance. Whenever statistics are involved, it's intrinsically harder to work with events that are rare, and it's something that's very intuitive to all statisticians. I've tried to explain why that's the case but it's useless if you don't listen
Coquenico t1_j60wbvq wrote
Reply to comment by watabadidea in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
> First, there is no clear explanation in the official report detailing what makes this particular answer easier to get than something like how effective it is at reducing hospitalizations.
They don't have to explain; anyone who's trained in statistics knows
It's always the same reason: you have many more people to work with; because comparatively very few people get hospitalized. It's like if you're trying to check if two dice are loaded, but there's one die you can roll every few seconds and another you can roll only once every hour
Of course if you could collect literally all data on all patients nationwide/worldwide you'd have enough cases, but one, the logistics of that would be extremely difficult to organize, and two, people in the US/Europe don't want such a totalitarian surveillance of their personal health anyway. So there's a limit to the scale of the studies that are practically feasible
None of these technicalities matter anyway. I don't think you realize just how much the cost/benefit ratio is skewed towards getting vaccinated. You're basically complaining that the weight of your car is given in pounds rather than in ounces
Coquenico t1_j605alq wrote
Reply to comment by watabadidea in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
well thats what i'm saying, that this isn't the complete answer
but it's partial simply because some answers are easier to get than others. Since the results are announced as we go, of course the answers for the simpler questions will be available first
but then, very importantly, having one answer already modifies the likelihoods for what the answers will be to the other questions -- that is, the expectations we can have regarding those other questions given our knowledge of related questions and our general knowledge of infectious diseases and immunology
specifically, if we know the booster works against the XBB variant in general, then it's very likely it also helps prevent serious illness/hospitalization
Coquenico t1_j5wdkgk wrote
Reply to comment by shiruken in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
yes its definitely harder to measure. anyway i only meant the present result is only the first half of the answer
Coquenico t1_j5w1asq wrote
Reply to The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
the real question is how much protection it offers against the hospitalization/death risk, and the long-term symptoms risk
Coquenico t1_j4wjdb4 wrote
it's simply because the earth is a sphere that's spinning
considering a spinning sphere, then there's an axis; that's your north-south direction. and then perpendicular to that are planes within which things are spinning -- if you're somewhere on the surface of the earth you're moving in a circle -- that's your east-west direction
note that the notion of north etc is completely unrelated to the sun, it only has to do with the earth's rotation
Coquenico t1_j48ent5 wrote
Reply to comment by kyoko9 in A systematic review and meta-analysis shows that the consumption of sugar-sweetened beverages was positively associated with an increased risk of metabolic syndrome. by glawgii
tbh this hardly qualifies as news at this point, sweet beverages are likely the single worst dietary habit one can have
Coquenico t1_j455utc wrote
Reply to comment by Choosyhealer16 in where does epinephrine comes from? The one used for people with allergies because Google only says It comes from glands so I don't understand if it's donated or sintethized by other means. by SALAMI_21
the thing is, you're getting the meat anyway. might as well save the glands
Coquenico t1_j6k57l9 wrote
Reply to comment by watabadidea in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
the metaphor is valid for epidemiology studies. at the core you're just tallying the chances of an objectively observable binary outcome in a series of predetermined groups
I'm not sure where your experiment of rolling infinitesimally loaded dice in a sealed black box is coming from but it's so completely absurd and disconnected from the practical and theoretical considerations associated with epidemiology that I needn't comment on it